These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21852622)

  • 21. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
    Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
    Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome.
    Saposnik G; Young B; Silver B; Di Legge S; Webster F; Beletsky V; Jain V; Nilanont Y; Hachinski V
    JAMA; 2004 Oct; 292(15):1839-44. PubMed ID: 15494581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of long-term outcome after intravenous or intra-arterial recombinant tissue plasminogen activator treatment in the eastern Hungarian thrombolysis database.
    Fekete K; Márton S; Tóth J; Csiba L; Fekete I; Bereczki D
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):117-24. PubMed ID: 25440339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum neuron specific enolase level as a predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis.
    Lu K; Xu X; Cui S; Wang F; Zhang B; Zhao Y
    J Neurol Sci; 2015 Dec; 359(1-2):202-6. PubMed ID: 26671113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.
    Muchada M; Rubiera M; Rodriguez-Luna D; Pagola J; Flores A; Kallas J; Sanjuan E; Meler P; Alvarez-Sabin J; Ribo M; Molina CA
    Stroke; 2014 Apr; 45(4):1059-63. PubMed ID: 24603070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple clinical and MRI scale to predict good outcome in t-PA patients.
    Kimura K; Sakamoto Y; Iguchi Y; Shibazaki K; Watanabe M; Aoki J; Inoue T; Uemura J
    Neurol Res; 2011 Dec; 33(10):1038-43. PubMed ID: 22196756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
    Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
    Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of obesity on stroke outcome after intravenous thrombolysis.
    Sarikaya H; Elmas F; Arnold M; Georgiadis D; Baumgartner RW
    Stroke; 2011 Aug; 42(8):2330-2. PubMed ID: 21757671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR).
    Ahmed N; Dávalos A; Eriksson N; Ford GA; Glahn J; Hennerici M; Mikulik R; Kaste M; Lees KR; Lindsberg PJ; Toni D;
    Arch Neurol; 2010 Sep; 67(9):1123-30. PubMed ID: 20837858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
    Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
    Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with early recanalization failure following intravenous rt-PA therapy for ischemic stroke.
    Koga M; Arihiro S; Miyashita F; Yamamoto H; Yamada N; Nagatsuka K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2013; 36(4):299-305. PubMed ID: 24135558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
    Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
    Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of both ends of the hemoglobin range on clinical outcomes in acute ischemic stroke.
    Park YH; Kim BJ; Kim JS; Yang MH; Jang MS; Kim N; Han MK; Lee JS; Lee J; Kim S; Bae HJ
    Stroke; 2013 Nov; 44(11):3220-2. PubMed ID: 24003047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.